Ratnaparkhe and colleagues also hypothesised that acquired germline ATM mutations are linked with the prevalence of Cht in ALL patients—any of the non-Cht sporadic cases did not exhibit mutated ATM, which is known to be an essential guardian of genome stability and it prevents DNA damage, i.a., deleterious lesions. The gene discussed is ATM; the disease is acute lymphoblastic leukemia.